Imricor Medical Systems Inc Asset Resilience Ratio
Imricor Medical Systems Inc asset resilience ratio. Imricor Medical Systems Inc (IMR) has an Asset Resilience Ratio of 46.50% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Imricor Medical Systems Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Imricor Medical Systems Inc (2023–2025)
Asset resilience ratio of Imricor Medical Systems Inc from 2023 to 2025. This chart shows how Imricor Medical Systems Inc's Asset Resilience Ratio has changed over time. Read IMR liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Imricor Medical Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Imricor Medical Systems Inc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$21.29 Million | 46.5% |
| Total Liquid Assets | AU$21.29 Million | 46.50% |
Asset Resilience Insights
- Very High Liquidity: Imricor Medical Systems Inc maintains exceptional liquid asset reserves at 46.50% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Imricor Medical Systems Inc Industry Peers by Asset Resilience Ratio
Compare Imricor Medical Systems Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Imricor Medical Systems Inc Asset Resilience Ratio by Year (2023–2025)
Imricor Medical Systems Inc asset resilience ratio by year from 2023 to 2025. The table below shows the annual Asset Resilience Ratio data for Imricor Medical Systems Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 46.50% | AU$21.29 Million ≈ $15.07 Million |
AU$45.79 Million ≈ $32.40 Million |
+51.16pp |
| 2023-12-31 | -4.66% | AU$-387.09K ≈ $-273.89K |
AU$8.31 Million ≈ $5.88 Million |
-- |
About Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more